Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gemigliptin - LG Chem

Next Previous
Search
Drug Profile

Gemigliptin - LG Chem

Alternative Names: Gemigliptin tartrate sesquihydrate; Gemiglo®; LC-150444; Zemiduo; Zemiglo; Zemimet

Latest Information Update: 18 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LG Life Sciences
  • Developer LG Chem; LG Life Sciences; Sanofi
  • Class Antihyperglycaemics; Piperidines; Pyrimidines; Small molecules
  • Mechanism of Action Dipeptidyl peptidase 4 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Type 2 diabetes mellitus
  • Phase II/III Acute kidney injury

Most Recent Events

  • 18 Nov 2024 Discontinued - Phase-III for Type 2 diabetes mellitus (Adjunctive treatment, Combination therapy, Treatment experienced) in Russia(PO) (NCT02343926)
  • 14 Nov 2024 Discontinued - Phase-I for Type 2 diabetes mellitus (In volunteers) in Germany, China (PO)
  • 14 Nov 2024 Discontinued - Phase-III for Type 2 diabetes mellitus (Adjunctive treatment, Treatment experienced) in USA (PO) (NCT01990469)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top